Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells. [electronic resource]
Producer: 20140926Description: 356-64 p. digitalISSN:- 1873-3441
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Cell Cycle Proteins -- genetics
- Cell Death -- genetics
- Cell Line, Tumor
- Cell Survival
- Endothelial Cells -- metabolism
- G2 Phase Cell Cycle Checkpoints -- genetics
- Gene Silencing
- Humans
- Inhibitory Concentration 50
- Liposomes
- Male
- Mitosis -- genetics
- Paclitaxel -- administration & dosage
- Prostatic Neoplasms -- genetics
- Protein Serine-Threonine Kinases -- genetics
- Proto-Oncogene Proteins -- genetics
- RNA, Messenger -- metabolism
- RNA, Small Interfering -- administration & dosage
- Polo-Like Kinase 1
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.